Groupon Inc (NASDAQ:GRPN) shares rose 3.3% in pre-market trading to $5.
In a research note published yesterday, Wedbush analyst David Nierengarten reaffirmed an Outperform rating on Anacor Pharmaceuticals (NASDAQ:ANAC) with a $35 price target, …
In a research note published July 18, Wedbush analyst David Nierengarten reiterated an Outperform rating on Anacor Pharmaceuticals (ANAC) and raised his price …
In a research note released yesterday, Wedbush analyst David Nierengarten reiterated an Outperform rating on Anacor Pharmaceuticals (ANAC) with a price target of …
